Lyrus Receives US FDA approval for Critical UTI treatment in the US
Lyrus has received US FDA approval for our Abbreviated New Drug Application (ANDA) for 'Methenamine Hippurate Tablets USP, 1 gram', an AB-rated, substitutable generic version of Hiprex®.
This approval marks a major milestone for Lyrus in the US market. It demonstrates our capabilities in bringing complex generics and difficult-to-manufacture products to patients who need them. Methenamine Hippurate is indicated for the prophylactic or suppressive treatment of frequently recurring urinary tract infections (UTIs) when long-term therapy is considered necessary. UTIs affect millions of patients globally each year, so there is a growing need for treatment options. Our rigorous analyses submitted to the FDA showed that Lyrus’ product has the same active ingredient, dosage form, route of administration and strength as the branded version. It will be produced in India and marketed in the US by our partner Jubilant Cadista Pharmaceuticals Inc.
Methenamine is used to prevent or control returning urinary tract infections caused by certain bacteria. It is not used to treat an active infection. Antibiotics must be used first to treat and cure the infection. Methenamine is a drug that stops the growth of bacteria in urine. This medication also contains an ingredient that helps to make the urine acidic. When the urine is acidic, methenamine turns into formaldehyde to kill the bacteria. This drug is effective only against bacterial infections in the urinary tract. It will not work for other types of bacterial infections (such as in the blood) or for viral infections (such as the common cold or flu). Unnecessary use or misuse of any antibacterial drug can lead to its decreased effectiveness.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance